Amryt Flies As Butterfly Skin Therapy Hits Late-Stage Goal

Market Worth In Excess Of $1bn

Butterflies
An EB patient’s skin can be as fragile as butterfly wings • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Clinical Trials

More from R&D